Aytu BioScience Receives Patent on Male Infertility Diagnostic

Aytu BioScience, Inc. (NASDAQ: AYTU) announced on 10/11/18 the issuance of a U.S. patent covering the company's proprietary MiOXSYS® diagnostic platform for male infertility. This is the first patent specifically covering fertility measurement methods with the MiOXSYS System and is the 15th U.S. patent overall covering the system's core oxidation-reduction potential (ORP) technology and its uses. The newly issued patent expires November 24, 2035.